The Many Faces of Philadelphia: A Mature T-Cell Lymphoma with Variant Philadelphia-Translocation and Duplication of the Philadelphia Chromosome.

IF 1.1 Q4 HEMATOLOGY
Livia Vida, Bálint Horváth, Miklós Egyed, Béla Kajtár, Hussain Alizadeh
{"title":"The Many Faces of Philadelphia: A Mature T-Cell Lymphoma with Variant Philadelphia-Translocation and Duplication of the Philadelphia Chromosome.","authors":"Livia Vida, Bálint Horváth, Miklós Egyed, Béla Kajtár, Hussain Alizadeh","doi":"10.3390/hematolrep17010001","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> T-cell prolymphocytic leukemia (T-PLL) is a rare mature T-cell lymphoma that is usually associated with poor prognosis and short overall survival. <b>Methods:</b> We present a case of a 61-year-old woman presenting with T-PLL and the leukemic cells harboring <i>BCR::ABL1</i> (<i>BCR</i>-breakpoint cluster region; <i>ABL1</i>-ABL protooncogene 1) fusion transcripts as the result of a variant of t(9;22)(q34;q11) called Philadelphia translocation: t(9;22;18)(q34;q11;q21). Sequencing revealed a rare <i>BCR</i> transcript with an exon 6 breakpoint corresponding to e6a2 transcripts, which has thus far been reported in only 26 cases of leukemias. <b>Results:</b> After 9 months of follow-up, the disease progressed and required treatment. Following alemtuzumab and chemotherapy, a short course of imatinib therapy stabilized the disease for six months, which was followed by progression and the demise of the patient. <b>Conclusions:</b> To the best of our knowledge, this is the first report of a mature T-cell lymphoma with a variant Philadelphia-translocation and a very rare type of <i>BCR::ABL1</i> transcript. This case highlights the importance of comprehensive genetic testing of malignancies, as abnormal molecular pathways may be uncovered that may be specifically targeted by drugs.</p>","PeriodicalId":12829,"journal":{"name":"Hematology Reports","volume":"17 1","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11755446/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/hematolrep17010001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: T-cell prolymphocytic leukemia (T-PLL) is a rare mature T-cell lymphoma that is usually associated with poor prognosis and short overall survival. Methods: We present a case of a 61-year-old woman presenting with T-PLL and the leukemic cells harboring BCR::ABL1 (BCR-breakpoint cluster region; ABL1-ABL protooncogene 1) fusion transcripts as the result of a variant of t(9;22)(q34;q11) called Philadelphia translocation: t(9;22;18)(q34;q11;q21). Sequencing revealed a rare BCR transcript with an exon 6 breakpoint corresponding to e6a2 transcripts, which has thus far been reported in only 26 cases of leukemias. Results: After 9 months of follow-up, the disease progressed and required treatment. Following alemtuzumab and chemotherapy, a short course of imatinib therapy stabilized the disease for six months, which was followed by progression and the demise of the patient. Conclusions: To the best of our knowledge, this is the first report of a mature T-cell lymphoma with a variant Philadelphia-translocation and a very rare type of BCR::ABL1 transcript. This case highlights the importance of comprehensive genetic testing of malignancies, as abnormal molecular pathways may be uncovered that may be specifically targeted by drugs.

费城的许多面孔:一个成熟的t细胞淋巴瘤与变异型费城-易位和复制费城染色体。
背景:t细胞前淋巴细胞白血病(T-PLL)是一种罕见的成熟t细胞淋巴瘤,通常预后差,总生存期短。方法:我们报告了一例61岁妇女,以T-PLL和白血病细胞窝藏BCR: ABL1 (BCR-断点簇区;ABL1-ABL原癌基因1)融合转录本是t(9;22)(q34;q11)的一种变体,称为费城易位:t(9;22;18)(q34;q11;q21)。测序发现了一个罕见的BCR转录本,其外显子6断点对应于e6a2转录本,迄今为止仅在26例白血病中报道过。结果:随访9个月后,病情进展,需要治疗。在阿仑单抗和化疗之后,短期的伊马替尼治疗使疾病稳定了6个月,随后是进展和患者的死亡。结论:据我们所知,这是首例成熟t细胞淋巴瘤伴变异型费城易位和一种非常罕见的BCR::ABL1转录物的报道。这个病例强调了对恶性肿瘤进行全面基因检测的重要性,因为可能会发现异常的分子途径,这些途径可能会被药物特异性靶向。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hematology Reports
Hematology Reports HEMATOLOGY-
CiteScore
0.90
自引率
0.00%
发文量
47
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信